Ofloxacin
Floxal contains the active substance ofloxacin, which belongs to a group of antibacterial medicines called fluoroquinolones. The medicine has antibacterial effects on certain aerobic and anaerobic bacteria.
The medicine is used to treat infections of the anterior segment of the eye, caused by microorganisms sensitive to ofloxacin, such as chronic conjunctivitis, keratitis, corneal ulcer, and chlamydial infection.
Before starting to use Floxal, the patient should discuss it with their doctor or pharmacist, especially in the following situations:
In case of a skin rash or any other allergic reaction to Floxal eye ointment, the patient should stop using the medicine and contact their doctor.
The doctor will then decide on the appropriate treatment.
During the use of Floxal eye ointment, the patient should avoid excessive exposure to sunlight or ultraviolet radiation (e.g., quartz lamps, solarium, etc.) due to the possibility of photosensitivity reactions.
Prolonged use of Floxal may lead to the multiplication of pathogenic microorganisms that are resistant to this medicine. In such a case, the doctor will decide on the appropriate treatment.
Tendonitis and tendon rupture have occurred in patients taking fluoroquinolones orally or intravenously, especially in older patients and those treated with corticosteroids at the same time. The patient should stop using Floxal eye ointment if they experience pain or swelling of the tendon (tendinitis).
The use of Floxal is not recommended in children under 1 year of age, as its safety and efficacy in this age group have not been established.
The patient should tell their doctor or pharmacist about all the medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
If Floxal eye ointment is used at the same time as other eye ointments or eye drops, the patient should keep a 15-minute interval between the administration of the medicines. Floxal eye ointment should be used last.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine. The doctor will decide whether the patient can use Floxal eye ointment.
Ofloxacin had no effect on fertility in animals.
Immediately after using the ointment, the patient may experience temporary, transient blurred vision. Until this effect has completely resolved, patients should not operate machines or drive vehicles.
The medicine may cause local skin reactions (e.g., contact dermatitis).
This medicine should always be used exactly as prescribed by the doctor or pharmacist. If the patient has any doubts, they should consult their doctor or pharmacist.
Recommended dose
On average, 1 cm of squeezed ointment (0.12 mg of ofloxacin) into the conjunctival sac 3 times a day (in the case of chlamydial infection 5 times a day).
Apply to the conjunctival sac of the infected eye.
Instructions for administering the medicine:
Having someone else help or using a mirror may make it easier to administer the medicine.
Floxal eye ointment is a sterile medicine. To avoid contamination, do not touch the nozzle with your fingers or touch it to the surface of the eye or any other surface.
Using contaminated eye ointment can lead to serious eye damage, including loss of vision.
Treatment with Floxal should not last longer than 2 weeks.
If the infection worsens or does not improve after a few days, the patient should contact their doctor.
In case of using more than the recommended dose of the medicine, the patient should rinse their eye with clean water.
If the medicine is accidentally ingested, the patient should contact their doctor immediately.
If a dose of Floxal is missed, the patient should use the medicine as soon as possible.
However, if it is almost time for the next dose, the patient should skip the missed dose and continue using the medicine according to the schedule prescribed by their doctor. The patient should not use a double dose to make up for the missed dose. If several doses are missed, the patient should inform their doctor and follow their advice.
Floxal should be used according to the doctor's instructions.
If the patient has any further doubts about using this medicine, they should consult their doctor or pharmacist.
Like all medicines, Floxal can cause side effects, although not everybody gets them.
which initially appear as reddish spots or oval patches on the torso, often with blisters in the center - the frequency of this side effect is unknown.
In addition, the following side effects may occur:
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: 22 49 21 301, fax: 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Store at a temperature below 25°C.
Discard any remaining ointment 4 weeks after first opening the tube.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Floxal is ofloxacin.
1 g of eye ointment contains 3 mg of ofloxacin.
The other ingredients are: liquid paraffin, lanolin, white petrolatum
Floxal is available as an eye ointment.
The available packaging of the medicine is: an HDPE tube with an HDPE cap, in a cardboard box.
For more detailed information, the patient should contact the marketing authorization holder or parallel importer.
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH
Brunsbutteler Damm 165-173
13581 Berlin
Germany
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH
Brunsbutteler Damm 165-173
13581 Berlin
Germany
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in the Czech Republic, the country of export: 64/368/00-C
Parallel import authorization number: 47/24
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.